Adding Melatonin to Colistin for Drug-Resistant Infections
Treatments studied
Part of Infections clinical trials.
This trial is testing whether adding melatonin to your standard treatment with colistin can help fight severe infections caused by drug-resistant bacteria. It aims to see if this combination improves recovery for patients in critical care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed infection caused by multidrug-resistant (hard-to-treat) bacteria.
- You are currently getting colistin, a strong antibiotic, through an IV.
- You have sepsis (a serious whole-body response to infection) or another severe infection.
- You are not pregnant or breastfeeding, and do not have a terminal illness, severe liver or kidney disease, or a serious mental health condition being treated with medication.
- You have not taken melatonin in the last 48 hours before joining the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving a medication (colistin) both through an IV and as a mist you breathe in works better for lung infections caused by bacteria that are hard to treat with standard antibiotics. It may help patients who have these tough bacteria and are in the hospital.
This trial tests if melatonin can improve sleep quality for patients in the intensive care unit (ICU). If you are able to take pills by mouth and are not on a breathing machine, this study might help you rest better.
This trial tests whether adding melatonin to standard chemotherapy before surgery can help treat breast cancer. The goal is to see if melatonin improves how well the chemotherapy works.
This trial tests whether adding melatonin to standard pneumonia treatment helps children recover faster. It is for children aged 1 month to 12 years with pneumonia or severe pneumonia.
This study tests two different pairs of strong antibiotics to see which works better at clearing hard-to-treat bacterial infections that don't respond to standard drugs. You would receive one of these two combinations and be monitored for how well it works and any side effects.
This trial tests a medicine called colistimethate sodium for people in the hospital with a serious infection (pneumonia or bloodstream infection) caused by a resistant bacteria called CRE. The goal is to see if this antibiotic can effectively treat the infection.
Hear when a new Antimicrobial Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.